Literature DB >> 33814821

Nodular Posterior Scleritis Masquerading as a Subretinal Mass.

Naseer Ally1, Aubrey Makgotloe1.   

Abstract

This is the case report of a 50-year-old female with no systemic comorbidities who presented to the eye clinic with a 1-month history of right-sided eye pain and visual loss. Examination revealed no signs of inflammation in the right eye, with no proptosis or conjunctival injection. A relative afferent pupillary defect was present with no inflammatory cells in the vitreous. On fundoscopy, there was a swollen disc, a large superior creamy white subretinal mass associated with a shallow overlying retinal detachment. B-scan ultrasonography confirmed the presence of a subretinal mass. Hematological investigations revealed an elevated erythrocyte sedimentation rate. Infective and autoimmune markers were negative. A diagnosis was made of nodular posterior scleritis and the patient was treated with intravenous corticosteroids initially, and subsequently switched to oral corticosteroids. There was complete resolution of the mass with optic atrophy as a result. Posterior nodular scleritis is an extremely rare potentially vision-threatening ocular condition that requires multimodal investigations to diagnose and treat appropriately. Copyright:
© 2021 Middle East African Journal of Ophthalmology.

Entities:  

Keywords:  Nodular scleritis; posterior scleritis; subretinal mass

Year:  2021        PMID: 33814821      PMCID: PMC7993044          DOI: 10.4103/meajo.MEAJO_216_19

Source DB:  PubMed          Journal:  Middle East Afr J Ophthalmol        ISSN: 0974-9233


  10 in total

1.  Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.

Authors:  P J McCluskey; P G Watson; S Lightman; J Haybittle; M Restori; M Branley
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

2.  Massive Granuloma of the Sclera (Brawny Scleritis), with the Report of an Unusual Case: Pathologic Examination by Dr. F. H. Verhoeff.

Authors:  G S Derby
Journal:  Trans Am Ophthalmol Soc       Date:  1915

3.  Clinical characteristics and ocular complications of patients with scleritis in Japanese.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Kazuyoshi Ohtomo; Mitsuko Takamoto; Keiko Komae; Jiro Numaga; Yujiro Fujino; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2018-05-23       Impact factor: 2.447

4.  NODULAR POSTERIOR SCLERITIS: Clinico-Sonographic Characteristics and Proposed Diagnostic Criteria.

Authors:  Rupesh Agrawal; Alenka Lavric; Marie Restori; Carlos Pavesio; Mandeep S Sagoo
Journal:  Retina       Date:  2016-02       Impact factor: 4.256

5.  Giant nodular posterior scleritis simulating choroidal melanoma.

Authors:  Dhananjay Shukla; Ramasamy Kim
Journal:  Indian J Ophthalmol       Date:  2006-06       Impact factor: 1.848

6.  Posterior scleritis as an intraocular tumour.

Authors:  P T Finger; H D Perry; S Packer; R A Erdey; G D Weisman; P A Sibony
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

7.  Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin.

Authors:  Robert L Johnston; Adnan Tufail; Susan Lightman; Philip J Luthert; Carlos E Pavesio; Robert J Cooling; David Charteris
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

8.  Severity of scleritis and episcleritis.

Authors:  M Sainz de la Maza; N S Jabbur; C S Foster
Journal:  Ophthalmology       Date:  1994-02       Impact factor: 12.079

9.  Clinical features and presentation of posterior scleritis: a report of 31 cases.

Authors:  Luis Alonso Gonzalez-Gonzalez; Nicolas Molina-Prat; Priyanka Doctor; Joseph Tauber; Maite Sainz de la Maza; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2013-10-16       Impact factor: 3.070

10.  [Giant nodular posterior scleritis compatible with ocular sarcoidosis simulating choroidal melanoma].

Authors:  E Pérez-Campagne; Y Guex-Crosier; A Schalenbourg; S Uffer; L Zografos
Journal:  Arch Soc Esp Oftalmol       Date:  2007-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.